Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice

Radiation Research

Volumn 178, Issue 3, 2012, Pages 202-206

  Kim, Jae Ho ^a   Kolozsvary, Andrew ^a   Jenrow, Kenneth A ^a   Brown, Stephen L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DRUG EFFICACY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; SKIN INJURY; STEM CELL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HETEROCYCLIC COMPOUNDS; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RECEPTORS, CXCR4; SKIN; TIME FACTORS;

MUS;

EID: 84866318218     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2886.1     Document Type: Article

References (21)

1. De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov 2003; 2: 581-7. (Pubitemid 37361749)
2. De Clercq E, Yamamoto N, Pauwels R, Balzarini J, Witvrouw M, De Vreese K, et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother 1994; 38: 668-74. (Pubitemid 24113999)
3. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E, et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receoptor, in human volunteers. Antimicrob Agents Chemother 2000; 44: 1667-73. (Pubitemid 30340812)
4. Lo Celso C, Scadden DT. The haematopoietic stem cell niche at a glance. J Cell Sci 2011; 124:3529-35.
5. Burroughs L, Mielcarek M, Little MT, Bridger G, Macfarland R, Fricker S, et al. Durable engraftment of AMD-3100 mobilized autologous and allogeneic peripheral-blood monocuclear cells in a canine transplantation model. Blood 2005; 106:4002-8. (Pubitemid 41739045)
6. Withers HR. The dose-survival relationship for irradiation of epithelial cells of mouse skin. Br J Radiol 1967; 40:187-94.
7. Kohl RR, Kolozsvary A, Brown SL, Kim JH. Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin- converting enzyme inhibitor. Radiat Res 2007; 168:440-5. (Pubitemid 351303172)
8. Kumar S, Kolozsvary A, Kohl R, Lu M, Brown SL, Kim JH. Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis. Radiat Oncol 2008; 3:40-5.
9. Liang L, Hu D, Liu W, Williams JP, Okunieff P, Ding I. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 2003; 26:S114-21. (Pubitemid 36961152)
10. Malkinson, FD, Geng, L, Hanson WR. Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin. J Invest Derm 1993; 101:135S-7S. (Pubitemid 23216898)
11. Chung YL, Wang AJ, Yao LF. Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther 2004; 3:317-25.
12. Yan S, Brown SL, Kolozsvary A, Freytag SO, Lu M, Kim JH. Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy. J Gene Med 2008; 10:1012-8.
13. Delanian S, Lefaix, JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 2007; 17:99-107. (Pubitemid 46476864)
14. Hill RP, Rodemann HP, Hendry JH, Roberts SA, Anscher MS. Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys 2001; 49:353-65. (Pubitemid 32123609)
15. Colvin GA, Dooner MS, Dooner GJ, Sanchez-Guijo FM, Demers DA, Abedi M, et al. Stem cell continuum: differentiation hotspots. Exp Hematol 2007; 35:96-107. (Pubitemid 46014373)
16. Chopp, M, Li, Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002; 1:92-100. (Pubitemid 37163494)
17. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98:10344-9. (Pubitemid 32803022)
18. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, et al. Transplantability and therapeutic effects of bone marrow derived mesenchymal cells in children with osteogenesis imperfect. Nat Med 1999; 5:309-13. (Pubitemid 29124367)
19. François S, Mouiseddine M, Mathieu N, Semont A, Monti P, Dudoignon N, et al. Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. Ann Hematol 2007; 86:1-8. (Pubitemid 46138311)
20. Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. Mobilization of bone marrow stem cells by G-CSF ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 2006; 12:1804-12.
21. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD-3100, a CXCR4 antagonist. J Exp Med 2005; 201:1307-18. (Pubitemid 40629073)